Location History:
- Tenafly, NJ (US) (1998 - 2003)
- Highland Park, IL (US) (2000 - 2007)
- Englewood, NJ (US) (2014)
- Bellaire, TX (US) (2019)
- Houston, TX (US) (2022 - 2024)
Company Filing History:
8 out of 1,521 
2 out of 601 
1 out of 3 
Years Active: 1998-2024
Title: Exploring the Innovations of Inventor Todd K. Rosengart
Introduction
Todd K. Rosengart, based in Highland Park, IL, is a prolific inventor renowned for his contributions to medical technology and cardiac treatments. With a remarkable portfolio of 12 patents, his work primarily focuses on advancements in cardiac health, showcasing a commitment to improving patient outcomes.
Latest Patents
Among his latest innovations, Rosengart has developed a patent titled "Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium." This groundbreaking method involves treating coronary artery disease in mammals by administering two vectors: one encoding angiogenic proteins to foster vascularization and another encoding cardio-differentiating transcription factors to promote the production of induced cardiomyocytes. Specifically, he employs an adenoviral vector encoding VEGF alongside a lentiviral vector encoding Gata4, Mef2c, and Tbx5 (GMT).
Additionally, he holds a patent for an "Apparatus and method for cutting a heart valve." This innovative apparatus includes a rotational axle device with non-mechanical cutting aspects, designed to protect the heart ventricle during surgical procedures. The methodology facilitates the cutting and removal of heart valve tissue, ensuring precision and safety until a percutaneous heart valve is securely in place.
Career Highlights
Todd K. Rosengart has achieved significant milestones in his career, particularly through his work at key research institutions. He has contributed his expertise to the Cornell Research Foundation Inc., among others, where his innovations have had substantial impacts on cardiac care and treatment methodologies.
Collaborations
Throughout his career, Rosengart has collaborated with esteemed colleagues including Ronald G. Crystal and Raymond A. Hartman. These partnerships have fostered an environment conducive to innovation, further advancing research in cardiac health.
Conclusion
In summary, Todd K. Rosengart stands out as a dedicated inventor with a notable influence in the field of cardiac health. His patents reflect a deep understanding of medical challenges and a relentless pursuit of solutions, positioning him as a key figure in medical innovations. His work not only enhances current practices but also paves the way for future breakthroughs in cardiovascular treatments.